Recent News

• 08.04.2026 - Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending
• 04.07.2026 - Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
• 03.26.2026 - Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
• 03.16.2026 - Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
• 11.19.2025 - Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
• 07.23.2025 - Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs
• 06.16.2025 - Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule
• 05.19.2025 - Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
• 05.13.2025 - Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
• 05.08.2025 - Alzamend Neuro Announces Reverse Stock Split

Recent Filings

• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 3 Initial statement of beneficial ownership of securities
• 08.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities
• 08.04.2026 - 5 Annual statement of changes in beneficial ownership of securities